Panel

Trevi Therapeutics to Participate in Upcoming Conferences

Retrieved on: 
torsdag, maj 9, 2024
Corporation, Idiopathic pulmonary fibrosis, University, NIHR, NHS foundation trust, IPF, Respiratory Medicine, Doctor of Philosophy, MB, Chronic cough, University of Manchester, Panel, RCC, FRCP, Therapy, Management

Corporate Presentation: May 14 at 12:00 p.m.

Key Points: 
  • Corporate Presentation: May 14 at 12:00 p.m.
  • ET
    Presenter: Jacky Smith, MB, ChB, FRCP, PhD, Professor of Respiratory Medicine at the University of Manchester, and an Honorary Consultant at Manchester University NHS Foundation Trust.
  • Director of the NIHR Manchester Clinical Research Facility, Respiratory Theme Lead in the NIHR Manchester Biomedical Research Centre and an NIHR Senior Investigator.
  • Panel Members: Experts in the field of chronic cough include Professor Peter Dicpinigaitis, Professor Jacky Smith, and Professor Alyn Morice.

Luokung Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Retrieved on: 
onsdag, maj 8, 2024
Panel, Failure, Calendar

Nasdaq's extension notice has no immediate effect on the continued listing status of the Company's ordinary shares on Nasdaq.

Key Points: 
  • Nasdaq's extension notice has no immediate effect on the continued listing status of the Company's ordinary shares on Nasdaq.
  • The Company was first notified by Nasdaq of its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A) on November 3, 2023, and was given until May 1, 2024 to regain compliance.
  • If the Company does not meet the minimum bid requirement during the additional 180-day extension, Nasdaq will provide written notification to the Company that its ordinary shares will be subject to delisting.
  • In addition, the Second Compliance Grace Period related exclusively to the bid price deficiency.

Green Ribbon Panel Unveils New Policy Recommendations for Green Economic Growth on World Asthma Day

Retrieved on: 
tisdag, maj 7, 2024
Climate change, Asthma Canada, ITC, Policy, Green ribbon, Health, NII, Electricity, Empire Club of Canada, Coal, Wind, Environment, World Asthma Day, Panel, Atmosphere, Asthma, Renewable energy

Today, World Asthma Day, the Green Ribbon Panel announced its continued work to advance policy recommendations that keep Canadians’ air clean while also supporting economic growth.

Key Points: 
  • Today, World Asthma Day, the Green Ribbon Panel announced its continued work to advance policy recommendations that keep Canadians’ air clean while also supporting economic growth.
  • On World Asthma Day, I’m pleased to see the Green Ribbon Panel continue to advance these recommendations that will help us all breathe a little easier.”
    Launched at an Empire Club of Canada event today in Toronto, the new report, titled Preserving progress and maintaining momentum , provides an update on its 2022 recommendations from the economic and environmental leaders that serve as members of the Green Ribbon Panel.
  • “The past two years have seen immense progress when it comes to creating the policy conditions needed to advance a clean economy,” said James Scongack, Chair of the Green Ribbon Panel.
  • Members of the Green Ribbon Panel:

T2 Biosystems Announces First Quarter 2024 Financial Results

Retrieved on: 
måndag, maj 6, 2024
FDA, ASPR, International, Research, ECCMID, U.S. FDA, ATM, Panel, Blood culture, CRG, Acinetobacter baumannii, Infection, Journal, Growth, Sepsis

LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced unaudited financial and operational results for the first quarter ended March 31, 2024.

Key Points: 
  • LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced unaudited financial and operational results for the first quarter ended March 31, 2024.
  • Advanced the T2Resistance Panel toward U.S. FDA 510(k) submission, expected to occur during the third quarter of 2024.
  • “Looking ahead, we plan to launch T2Lyme Panel and file the FDA submission for the T2Resistance Panel during the third quarter of 2024.
  • The Company raised $2.2 million in net proceeds through ATM sales in the first quarter of 2024.

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

Retrieved on: 
måndag, maj 6, 2024
Hearing, Notice, Letter, Form, Panel, Calendar

According to the Letter, the Company had not regained compliance with the Minimum Bid Requirement as of April 29, 2024, and is not eligible for a second 180-day period.

Key Points: 
  • According to the Letter, the Company had not regained compliance with the Minimum Bid Requirement as of April 29, 2024, and is not eligible for a second 180-day period.
  • Specifically, the Company does not comply with the initial listing requirement of $5,000,000 minimum stockholders’ equity for The Nasdaq Capital Market, as contemplated for a second 180-day period.
  • The Company plans to appeal the Determination to the Panel in due course.
  • A hearing request will stay the suspension of the Company’s securities and the filing of Form 25-NSE pending the Panel’s decision.

Collective Audience Appoints Award-Winning Digital Strategy Executive and Advertising Leader, Cary Tilds, to Advisor Collective

Retrieved on: 
måndag, maj 6, 2024
DLT, WPP plc, DMR, Interactive Advertising Bureau, WPP, Intelligence, SVP, MNTN, Television, Mind share, Advertising, Connected, Digital technology, Machine learning, Publication, AOL, API, Smart TV, Omnicom Group, Blockchain, Reality–virtuality continuum, Marketing, Ford Motor Company, Woman, Collective, IAB, Medialink, Adtech (company), Martech, Panel, NFT, UC

Tilds is an award-winning digital advertising executive with 30 years of experience driving digital strategies, marketing, technology and innovation for Fortune 500 media giants that include WPP, Mindshare, Omnicom, and Ford Motor Company.

Key Points: 
  • Tilds is an award-winning digital advertising executive with 30 years of experience driving digital strategies, marketing, technology and innovation for Fortune 500 media giants that include WPP, Mindshare, Omnicom, and Ford Motor Company.
  • “She brings to our growing Advisor Collective invaluable knowledge and insights gained from leading teams engaged across marketing, digital media and analytics, business intelligence and data strategies.
  • Tilds earlier served as SVP of digital strategy and SVP of corporate strategy at FordDirect, where she led its digital technology, analytics, business intelligence, and data strategy teams.
  • She is also founder and CEO of Cary Tilds Consulting, and was appointed to Google’s first customer advisor board.

Zycus to Host Horizon 2024, the Premier Conference for Procurement Innovation on May 15-17

Retrieved on: 
onsdag, maj 8, 2024
Payments, Data Management, Security, Technology, Software, Networks, Artificial Intelligence, Empowerment, Conference, Business, Blueprint, Horizon, Multimedia, Panel

Zycus, the pioneer in Generative AI-powered Source-to- Pay solutions , announces Horizon 2024, its annual conference dedicated to the future of procurement technology.

Key Points: 
  • Zycus, the pioneer in Generative AI-powered Source-to- Pay solutions , announces Horizon 2024, its annual conference dedicated to the future of procurement technology.
  • It will take place from May 15 - 17, 2024, at the St. Regis Bal Harbour Resort in Miami, Florida.
  • View the full release here: https://www.businesswire.com/news/home/20240508793632/en/
    Horizon 2024 - Zycus' Premier Procurement Conference (Graphic: Business Wire)
    “Horizon is crafted to offer a unique event experience that goes beyond typical conferences, fostering two-way dialogues over one-way presentations.
  • Horizon 2024 will challenge your assumptions and equip you with the tools to reimagine the future of your business,” says Aatish Dedhia, Founder & CEO of Zycus.

ENTRÉE RESOURCES ANNOUNCES FIRST QUARTER 2024 RESULTS

Retrieved on: 
onsdag, maj 8, 2024
Copper, Conversation, State, Tribunal, Partnership, Corporate development, Oyu Tolgoi mine, Shaft, TSX, National Instrument 43-101, Management, Technical report, Multilateral, ETG, National instrument, Minority, Panel, Government, Mineral, Capital, Toronto Stock Exchange, Rio Tinto, Technical, Bank statement, Mining

VANCOUVER, BC, May 8, 2024 /PRNewswire/ - Entrée Resources Ltd. (TSX: ETG) (OTCQB: ERLFF) – the "Company" or "Entrée") has today filed its interim financial results for the first quarter ended March 31, 2024.

Key Points: 
  • VANCOUVER, BC, May 8, 2024 /PRNewswire/ - Entrée Resources Ltd. (TSX: ETG) (OTCQB: ERLFF) – the "Company" or "Entrée") has today filed its interim financial results for the first quarter ended March 31, 2024.
  • In the first quarter 2024, OTLLC delivered 1.3 million tonnes of ore milled from Panel 0 on the Oyu Tolgoi mining licence at an average copper head grade of 1.67%.
  • Commissioning is expected to be progressively completed from the fourth quarter 2024 through to the second quarter 2025.
  • First Lift 1 Panel 1 development work on the Shivee Tolgoi mining licence is expected to commence in the fourth quarter 2024.

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

Retrieved on: 
måndag, maj 6, 2024
Sale, Inflammation, Hearing, Rule, CDMO, ADS, Letter, American depositary receipt, Staff, Panel, I&I

JERUSALEM, May 6, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it had had received a staff determination letter (the "Letter") on April 30, 2024 from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule"), the Company's American Depositary Shares ("ADSs") would be scheduled for delisting from The Nasdaq Capital Market and would be suspended for trading at the opening of business on May 7, 2024 unless the Company timely requests a hearing before an independent Nasdaq Hearings Panel (the "Panel"). 

Key Points: 
  • The Company was provided an initial 180-day grace period, or until April 29, 2024, to regain compliance with the Rule.
  • The Company has today appealed the delisting determination and requested a hearing before the Panel.
  • Such a request automatically stays any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Panel after the hearing.
  • During the period before the hearing, if any, the ADSs shares will continue to trade on Nasdaq.

Quantum Provides Updated Plan to Nasdaq

Retrieved on: 
fredag, maj 3, 2024
Hardware, Other Defense, Contracts, Security, Data Management, Technology, Audio, Video, Professional Services, Defense, Asset Management, Artificial Intelligence, Telecommunications, Software, Networks, Internet, Quantum Corporation, Corporation, AI, ASC, Panel, Quantum, File

Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), a leader in solutions for AI and unstructured data, today provided an update related to the Company’s efforts to become current with its SEC financial reports.

Key Points: 
  • Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), a leader in solutions for AI and unstructured data, today provided an update related to the Company’s efforts to become current with its SEC financial reports.
  • As previously announced on April 12, 2024, The Nasdaq Stock Market LLC (Nasdaq) granted Quantum’s request to stay the suspension of delisting of its common stock pending a scheduled hearing on May 14, 2024 with the Nasdaq Hearings Panel.
  • In advance of the scheduled hearing, Quantum submitted a written submission to Nasdaq on April 24, 2024 detailing its plans to regain compliance with the applicable Nasdaq listing criteria within the period of time that the Panel may grant.
  • Among other details, the updated plan outlines the Company’s progress and coordination with its advisors and auditors toward reaching the Company’s final determination with regards to the application of ASC Topic 606.